Evidence & citations 3 cited values
Every value below carries the sentence it was read from.
2 sources stand behind the page.
| Field | Value | Cited text |
|---|
| Known as |
PRECIOUS-01 |
ClinicalTrials.gov intervention name — accepted as the source's own label NCT04751786 ↗
|
| Modality |
Other / unclassified |
“The investigators study a new class of immunomodulatory nanomedicines: PLGA nanoparticles loaded with a tumor antigen and an iNKT cell agonist.” NCT04751786 ↗
|
| Route |
Intravenous |
“PRECIOUS-01 administered intravenously in subjects with advanced NY-ESO-1-expressing solid tumours.” PMID 34848513 ↗ Nov 2021
|